» Articles » PMID: 24452373

Extracellular Membrane Vesicles As a Mechanism of Cell-to-cell Communication: Advantages and Disadvantages

Overview
Specialties Cell Biology
Physiology
Date 2014 Jan 24
PMID 24452373
Citations 236
Authors
Affiliations
Soon will be listed here.
Abstract

Microvesicles represent a newly identified mechanism of intercellular communication. Two different types of microvesicles have been identified: membrane-derived vesicles (EVs) and exosomes. EVs originate by direct budding from the plasma membrane, while exosomes arise from ectocytosis of multivesicular bodies. Recent attention has focused on the capacity of EVs to alter the phenotype of neighboring cells to make them resemble EV-producing cells. Stem cells are an abundant source of EVs, and the interaction between stem cells and the microenvironment (i.e., stem cell niche) plays a critical role in determining stem cell phenotype. The stem cell niche hypothesis predicts that stem cell number is limited by the availability of niches releasing the necessary signals for self-renewal and survival, and the niche thus provides a mechanism for controlling and limiting stem cell numbers. EVs may play a fundamental role in this context by transferring genetic information between cells. EVs can transfer mRNA and microRNA to target cells, both of which may be involved in the change in target-cell phenotype towards that of EV-producing cells. The exchange of genetic information may be bidirectional, and EV-mediated transfer of genetic information after tissue damage may reprogram stem cells to acquire the phenotypic features of the injured tissue cells. In addition, stem cell-derived EVs may induce the de-differentiation of cells that survive injury by promoting their reentry into the cell cycle and subsequently increasing the possibility of tissue regeneration.

Citing Articles

Role of Perinatal Stem Cell Secretome as Potential Therapy for Muscular Dystrophies.

Pacilio S, Lombardi S, Costa R, Paris F, Petrocelli G, Marrazzo P Biomedicines. 2025; 13(2).

PMID: 40002871 PMC: 11852414. DOI: 10.3390/biomedicines13020458.


Folic Acid-Modified Milk Exosomes Delivering c-Kit siRNA Overcome EGFR-TKIs Resistance in Lung Cancer by Suppressing mTOR Signaling and Stemness.

Xu Z, Wang L, Tu L, Liu T, Zhang Y, He Y Int J Biol Sci. 2025; 21(1):382-399.

PMID: 39744423 PMC: 11667802. DOI: 10.7150/ijbs.99954.


Exosomes in infectious diseases: insights into leishmaniasis pathogenesis, immune modulation, and therapeutic potential.

Abida , Alhuthali H, Alshehri J, Alkathiri A, Almaghrabi R, Alsaeed S Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39702600 DOI: 10.1007/s00210-024-03702-7.


Toxoplasma gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma gondii.

Zhao L, Sun Q, Wang C, Liu J, Yan X, Shao M Int J Nanomedicine. 2024; 19:12421-12438.

PMID: 39600411 PMC: 11590659. DOI: 10.2147/IJN.S483626.


Intraosseous Delivery of Mesenchymal Stem Cells for the Treatment of Bone and Hematological Diseases.

Artamonov M, Sokov E Curr Issues Mol Biol. 2024; 46(11):12672-12693.

PMID: 39590346 PMC: 11592824. DOI: 10.3390/cimb46110752.